December 2010
Pharmaceutical Representative;Dec2010, Vol. 40 Issue 12, p11
The article reports on the approval of Egrifta from EMD Serono for treating HIV patients with lipodystrophy.


Related Articles

  • Pipeline preview.  // Formulary;Sep2003, Vol. 38 Issue 9, p512 

    Reports on developments related to drug approvals in the U.S. Designation of Timolol for the treatment of glaucoma; List of orphan drug designations.

  • Drugs in the News.  // Clarendon Enterprise (TX);4/24/2008, Vol. 19 Issue 17, p7 

    The article reports on the approval of a new facial wrinkle filler, Prevelle Silk, by the U.S. Food and Drug Administration (FDA) in the U.S.

  • 2007 Drug Approvals.  // American Journal of Health-System Pharmacy;2/1/2008, Vol. 65 Issue 3, p192 

    The article lists new molecular entities (NMEs) and new biological products for 2007 in the U.S. which include Nebivolol hydrochloride oral tablets for the treatment of hypertension, Ambrisentan oral tablets for the treatment of pulmonary arterial hypertension, and Thrombin as an aid to...

  • NEW DRUGS.  // Drug Topics;3/3/2003, Vol. 147 Issue 5, p94 

    Reports on drugs approved in the United States. Auxilium Pharmaceuticals' Testim drug for treating low levels of testosterone in men; Bradley Pharmaceuticals division, Kenwood Therapeutics' hemorrhoid therapy, AnaMantle HC.

  • NEW FORMULATIONS.  // Drug Topics;3/3/2003, Vol. 147 Issue 5, p94 

    Reports on drugs approved in the United States. Biovail Corp.'s cardizem LS, a long-acting formulation of the calcium-channel blocker indicated for control of hypertension; Muscle relaxant, Flexeril from McNeil Consumer & Specialty Pharmaceuticals.

  • Drug Approval in Canada. Hancock, Michelle // Alive: Canada's Natural Health & Wellness Magazine;Aug2003, Issue 250, p108 

    Examines the drug approval system of Canada. Creation of an organization to improve drug monitoring; Need for drug manufacturers to submit a drug's safety and efficacy using results from tissue sample, animal and human studies; Drug use for children.

  • The missing data that cost $20bn. Abbasi, Kamran // BMJ: British Medical Journal;4/12/2014, Vol. 348 Issue 7953, preceding p1 

    An introduction to the journal is presented in which the editor discusses articles published within the issue including one on neuraminidase inhibitors, another on the sales of oseltamivir (Tamiflu), and one on releasing full clinical trial data.

  • NEW FORMULATIONS.  // Drug Topics;7/07/2003, Vol. 147 Issue 13, p87 

    Reports on drugs approved for public release in the United States. Available dosage of Adoxa acne therapy from Bioglan Pharmaceuticals; Prefilled syringe for Avonex; Allergan Inc.'s receipt of approval for Acular LS, a ketorolac tromethamine ophthalmic solution.

  • India looks into drug approval procedures.  // BioSpectrum;Jun2012, Vol. 10 Issue 6, p20 

    The article announces the creation of a committee which will consist of renowned figures in science to look into drug approval procedures in India.

  • Drugs, new and improved. Clemons, Rachel // Choice;Oct2012, p11 

    The article reports that 795 medicines have been approved for use by Australia's drug regulator in the last decade and its benefits for cancer and heart disease patients, according to the report titled "Medicines Milestones" commissioned by The Australian Medicines Industry.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics